CleveMed’s NeuroSense line is undergoing testing in the U.S. and Europe and is awaiting clearance for sale in both locations, according to the report. It is still developing its seizure detection products.
Read the Crain’s report about CleveMed’s license agreement with NeuroWave.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
